Introduction

Methicillin-resistant
Staphylococcus aureus (MRSA) is an important nosocomial pathogen with an increasing incidence worldwide in recent years. ' -*
In Ireland MRSA became a major problem in the late 1 97Os5q6 and the incidence is now increasing. Since 1987 this increase has become evident in the group of hospitals served by this laboratory. ' An antibiogram-resistogram (AR) typing scheme able to provide results within 24 h and suitable for use in the diagnostic laboratory is described in an accompanying paper.* Here we report an evaluation of this typing scheme.
Materials and methods
Hospitals
The Microbiology Department of the Central Pathology Laboratory at St James's Hospital (SJH) serves SJH and the Federated Dublin Voluntary Hospitals (FDVH) group of hospitals. This group consists of Received 1 1 Jan. 1994; accepted 1 July 1994.
three acute general hospitals and one paediatric hospital. In 1992, the hospital group had a bed complement of 1243 and 56330 admissions, with an MRSA incidence of 0-7 YO of admissions.
Antibiogram-resistogram typing
Bacterial isolates. MRSA isolated between 20 Dec. 1992 and 31 Aug. 1993 were typed. One isolate from each patient was tested unless routine susceptibility test results indicated the presence of more than one strain. Isolates (535) were collected from 347 patients, 12 staff members and four environmental specimens. A further 26 isolates from six other Dublin hospitals were also typed. Fresh isolates were typed as soon as possible after isolation or stored frozen at -70°C on cryoprotective beads (Protect ; Technical Service Consultants Ltd).
Isolates were identified by testing for the production of clumping factor, coagulase and thermostable D N A S~.~.~' Since 5 April 1993, isolates were also identified with a S. aureus identification kit (Pastorex@ Staph-Plus ; Sanofi Diagnostics Pasteur). Methicillin susceptibility was tested at 30°C on Columbia blood agar (CBA) with 25-pg methicillin strips (Mast) and a 
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Results
Care was taken to ensure that the inoculum density produced the required " dense but not confluent " The incidence of MRSA in this group of hospitals growth and that incubation was continued for a between Aug. 1992 and Aug. 1993 is shown in fig. 1 . minimum 18-h period. Zones smaller than the control AR typing divided this MRSA population into 31 AR were measured with a pair of calipers and the zone types (seven types were further divided into subtypes); sizes were recorded. Susceptibility category was 90% of all isolates belonged to seven types (table I) . interpreted according to the Stokes' technique criteria.
The relative frequency with which these types occurred among isolates in this hospital group is shown in table 11. Fig. 2 shows the distribution of the five most common AR types among patients acquiring MRSA in hospitals 1, 2 and 3 respectively. Because there was a low incidence of MRSA in hospital 4, the AR type distribution for this hospital is not shown. The relative proportion of patients yielding AR types 13 and 14 in hospitals 1 and 2 was markedly different (8.9% and 29.7 YO in hospital 1 compared with 60 YO and 12.9 YO in hospital 2). In hospital 3, the incidence of AR type 13 was rising.
The higher incidence ( fig. 1 ) and more complex AR type distribution pattern ( fig. 2 ) among MRSA isolates from hospital 1 was due in part to the fact that hospital 1 was the largest hospital in the group (in 1992, hospitals 1,2, 3 and 4 had 722, 250, 180 and 91 beds respectively). In hospital 1 there was a sharp increase in AR type 14 between January and April and a decrease in AR type 11 during the same period ( fig. 2) .
The remaining two frequently occurring AR types in hospital 1 were AR types 15 AR type 14 in hospital 1 and AR type 13 in hospital 2, a series of smaller outbreaks was also occurring. For example, in hospital 1 between April and June, there was a peak in the incidence of AR type 6, while AR type 7 showed a series of peaks between January and August. In contrast, the incidence of AR type 11 fell steadily until May but increased between June and July. In addition to the more frequently occurring types, recognition of new AR types may confirm the introduction of new strains; for example, AR type 23 was isolated from a patient who had been hospitalised in Croatia.14 AR typing detected an unusual rifampicin-resistant strain (AR type 22) that caused the nosocomial ICU outbreak mentioned earlier. The typing scheme differentiated the outbreak strain from other M RSA isolates cultured from patients and staff in the ICU during the outbreak.
The emergence of mupirocin resistance was observed in MRSA in this hospital group in 1993; 82 % of mupirocin-resistant isolates belonged to AR type 13 and most (82 Yo) of these isolates were cultured from patients in hospital 2. Patients in other hospitals from whom this mupirocin-resistant MRSA was isolated were frequently found to have been transferred from hospital 2.
AR types 13 and 14 accounted for half (50.8 YO) the MRSA isolates typed. These types differed only with respect to lincomycin (or clindamycin) resistance and while it would be preferable not to rely on a single reaction to distinguish two types, epidemiological evidence from this study supported the conclusion that AR types 13 and 14 were different.
When AR typing was applied to 26 isolates from six other Dublin hospitals, all isolates belonged to AR types encountered in the SJH/FDVH hospital group; 56% of isolates belonged to AR type 13 (compared with 60% in hospital 2).
Discussion
Although MRSA have been a major problem in Dublin for > 15 years, until recently only a limited number of MRSA phenotypes had been described.15* l 6 The plasmid profiles and AR types of the majority of the MRSA population in this study differed from earlier phenotypes and showed sufficient diversity to make AR typing feasible. In the ideal typing scheme, not more than 5 YO of epidemiologically unrelated isolates should belong to the same type." In practice, it may be difficult to determine whether isolates are epidemiologically unrelated in a city like Dublin, where many medical specialities are centralised and there is constant patient and staff transfer among hospitals.
Approximately 60 O h of MRSA throughout the city appear to belong to AR type 13 but many of these isolates may be epidemiologically related. This result is based on a small random sample and may be an indication of the extent of inter-hospital MRSA cross-infection in Dublin. A prospective citywide survey would be helpful to determine the extent of the problem and the AR type distribution of the overall population.
Within this hospital group, AR typing has shown an obvious trend in hospitals 2 and 3 where AR type 13 isolates predominated. In hospital 1 a more complex pattern has emerged. Although the incidence of all MRSA isolates rose in April ( fig. 1) , AR type analysis indicated that the incidence of AR type 14 increased in March and its decline in April coincided with an increasing incidence of AR types 6 and 7 ( fig. 2) . Monitoring the varying incidence of different AR types can provide an early indication of trends that may be difficult to perceive in areas with an extensive endemic MRSA problem. AR typing may also detect small incidences of cross-infection that might otherwise go unnoticed.
The sharp increase in MRSA incidence in hospital 1 in April may have been due to an intensive screening programme and the introduction of salt enrichment to improve MRSA isolation from screening specimens.18 These measures were introduced in response to an outbreak in the ICU. The decreasing incidence since May may be a consequence of these measures and the introduction of stringent infection control protocols. Between April and June, the incidence of AR type 14 decreased dramatically.
The most common AR types encountered, AR types 13 and 14, appear to be closely related. With AR typing, the only distinguishing reaction occurred with lincomycin (or clindamycin). AR types 13 and 14 are indistinguishable on phage typing, plasmid profiling, restriction endonuclease analysis or enterotoxin production. Epidemiological evidence indicates that they are two distinct types as shown by the differing incidence in hospitals 1 and 2 ( fig. 2 ) and by the fact that when MRSA of AR type 13 was isolated in hospital 1, the patient had often been transferred from hospital 2. Further evidence may be obtained from hospital 2 where mupirocin resistance emerged in AR type 13. The initial mupirocin-resistant isolates were cultured from patients who had been on prolonged mupirocin therapy. Resistance was almost entirely restricted to AR type 13 and although this was the predominant type isolated in this hospital, AR type 14 was also present but mupirocin resistance did not emerge in this strain.
The distinction between AR types 13 and 14 was helpful in hospital 3 where the increasing incidence of MRSA ( fig. 2 ) was thought to have resulted from the admission of an MRSA patient from an external hospital. The majority of MRSA isolates from hospital 3 belonged to AR type 13 but the isolate from the presumed index case was AR type 14. Patients were frequently transferred to this hospital from hospital 2 where AR type 13 predominated. Thus, it was likely that a transferred patient from hospital 2 and not the external hospital was the source. Confirmation of the difference between AR types 13 and 14 may be possible by either pulsed field gel electrophoresis or random amplification of polymorphic DNA by polymerase chain reaction (RAPD-PCR).lS2l
In addition to epidemiological information, AR typing can provide clinically useful information on the antimicrobial susceptibility pattern of the MRSA population. For example, this study population was largely susceptible to trimethoprim, tetracycline and fusidic acid while the most frequently occurring AR types were ciprofloxacin resistant (table I) . Information regarding susceptibility to antibiotics not routinely tested in the diagnostic laboratory may also be available from the AR type: for example, if mupirocin is not routinely tested, the AR type will indicate resistant isolates.
This AR typing method has proved valuable in monitoring the MRSA population in this group of hospitals. It has demonstrated the heterogeneity of the present MRSA population and the extent to which this population is changing, and has recognised the introduction of new strains. AR typing has shown that, in addition to major outbreaks, a series of concurrent small outbreaks contributed to the MRSA problem in this hospital group.The method is suitable for use in the diagnostic laboratory and produces results within 24 h.
